Catalyst Wire Dossier Catalyst Wire Dossier

Herceptin SC

trastuzumab · Genentech, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Herceptin SC, covering 2016-03-25 to 2024-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast Cancer [Phase 2]

See pricing